Functional Residual Capacity During Different Levels of High-flow in Preterm Infants
FunkFlow
The FUNK-FLOW Study - Functional Residual Capacity During Different Levels of High-flow in Preterm Infants
1 other identifier
interventional
20
1 country
1
Brief Summary
Although there is a widespread use of HighFlow therapy around the world, there is still uncertainty about the most appropriate initial HighFlow level after nasal continuous positive airway pressure therapy. Higher levels might produce excessive and harmful intra-alveolar pressures exceeding those reached during nasal continuous positive airway pressure therapy. Low levels may not generate sufficient distending pressures, which may result in a loss of functional residual capacity and an increased risk of respiratory failure. Therefore, the aim of this study is to assess the effect of different HighFlow levels on the functional residual capacity and to compare these findings to the functional residual capacity during nasal continuous positive airway pressure therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
February 14, 2022
CompletedStudy Start
First participant enrolled
February 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2023
CompletedJuly 9, 2024
July 1, 2024
11 months
February 2, 2022
July 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in global end-expiratory lung impedance (EELI) during the weaning procedure from nasal continuous positive airway pressure (nCPAP) to HighFlow (HF)
Change in global EELI over time using electrical impedance tomography (EIT)
230-minute recording period per patient, 30 minutes on each HF level
Secondary Outcomes (11)
Change in mean respiratory rate (RR) during the weaning procedure from nasal continuous positive airway pressure (nCPAP) to HighFlow (HF)
230-minute recording period per patient, 30 minutes on each HF level
Change in regional end-expiratory lung impedance (EELI) during the weaning procedure from nasal continuous positive airway pressure (nCPAP) to HighFlow (HF)
230-minute recording period per patient, 30 minutes on each HF level
Change in mean minute volume during the weaning procedure from nasal continuous positive airway pressure (nCPAP) to HighFlow (HF)
230-minute recording period per patient, 30 minutes on each HF level
Change in mean ventilation distribution during the weaning procedure from nasal continuous positive airway pressure (nCPAP) to HighFlow (HF)
230-minute recording period per patient, 30 minutes on each HF level
Change in mean silent spaces during the weaning procedure from nasal continuous positive airway pressure (nCPAP) to HighFlow (HF)
230-minute recording period per patient, 30 minutes on each HF level
- +6 more secondary outcomes
Study Arms (1)
High Flow
OTHERStandard HighFlow therapy after weaning from continuous positive airway pressure therapy will be applied on different flow levels. Starting with a flow level of 8l/min, the flow-rates will be changed every 30 minutes subsequently from 8-6-4-2-4-6-8 l/min. Meanwhile, data lung volume changes will be measured using electrical impedance tomography.
Interventions
Standard HighFlow therapy after weaning from continuous positive airway pressure therapy will be applied on different flow levels. Starting with a flow level of 8l/min, the flow-rates will be changed every 30 minutes subsequently from 8-6-4-2-4-6-8 l/min. Meanwhile, data on lung volume changes will be measured using electrical impedance tomography.
Eligibility Criteria
You may qualify if:
- Written Informed Consent by one or both parents or legal guardians as documented by signature
- weeks postmenstrual age
- Respiratory support with nCPAP PEEP 5mbar and FiO2 \< 0.30
- \> 72 hours old
You may not qualify if:
- Inability of the parents to understand the study concept or procedures due to cognitive or linguistic reasons
- Congenital malformations adversely affecting lung aeration or pulmonary perfusion (e.g. congenital heart or lung defects)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Newborn Research, Department of Neonatology, University Hospital Zurich
Zurich, 8091, Switzerland
Related Publications (3)
Collins CL, Holberton JR, Barfield C, Davis PG. A randomized controlled trial to compare heated humidified high-flow nasal cannulae with nasal continuous positive airway pressure postextubation in premature infants. J Pediatr. 2013 May;162(5):949-54.e1. doi: 10.1016/j.jpeds.2012.11.016. Epub 2012 Dec 20.
PMID: 23260098BACKGROUNDFrerichs I, Amato MB, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, Bodenstein M, Gagnon H, Bohm SH, Teschner E, Stenqvist O, Mauri T, Torsani V, Camporota L, Schibler A, Wolf GK, Gommers D, Leonhardt S, Adler A; TREND study group. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017 Jan;72(1):83-93. doi: 10.1136/thoraxjnl-2016-208357. Epub 2016 Sep 5.
PMID: 27596161BACKGROUNDvan der Burg PS, Miedema M, de Jongh FH, Frerichs I, van Kaam AH. Cross-sectional changes in lung volume measured by electrical impedance tomography are representative for the whole lung in ventilated preterm infants. Crit Care Med. 2014 Jun;42(6):1524-30. doi: 10.1097/CCM.0000000000000230.
PMID: 24561568BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2022
First Posted
February 14, 2022
Study Start
February 19, 2022
Primary Completion
January 13, 2023
Study Completion
January 13, 2023
Last Updated
July 9, 2024
Record last verified: 2024-07